Mammalian Cell Bioreactors 1. Well-Mixed Stirred-Tank Reactor: in An Ideal Well-Mixed Bioreactor, The Mixing Is Assumed To
Mammalian Cell Bioreactors 1. Well-Mixed Stirred-Tank Reactor: in An Ideal Well-Mixed Bioreactor, The Mixing Is Assumed To
manufacturing is crucial for worldwide disease control and eradication. Vaccination implies the
administration of attenuated or inactivated infectious agents (or their components) delivering
antigenic structures that stimulate the adaptive immune system in order to elicit an effective
response against specific pathogens to prevent future infections.
On mammalian cell culture based vaccine production, cell line selection is a critical step.
Initially, diploid cells were favored for production because of safety due to their non-
tumorigenic potential in animals. In 1980s vero cell line gained approval for production of
vaccines with the production of Polio vaccines. The latest mammalian cell line to be used in an
approved vaccine is the Madin Darby Canine Kidney (MDCK) line that has been adapted to
suspension culture, used in the manufacture of Flucelvax by Novartis.
Bioreactors In Vaccine Production
Bioreactors are currently being used in vaccine manufacturing and their use will likely continue
to expand. Bioreactors can provide cells the optimum environment, which can lead to an
increase in productivity and reduced overall cost. While many vaccines are still manufactured
using static culture or roller bottles, several studies have shown that manufacturing can be
greatly improved by employing bioreactors. The principal advantage of bioreactors and the
reason for their successful implementation in vaccine manufacturing processes is the
unsurpassed scale-up advantage.
Mammalian cell bioreactors
1. Well-mixed stirred-tank reactor: In an ideal well-mixed bioreactor, the mixing is assumed to
be intense enough that the fluid is homogeneous through the reactor. The mathematical
description of ideal continuous flow stirred-tank reactor is described by the following first-order
differential equation.
where vz is the linear velocity in the z direction and S is the cross-sectional area.
Bioreactors can be used when cells are in suspension or adherent by employing another
technology – microcarriers. Microcarrier materials are typically porous (macroporous) or non-
porous beads made of glass, plastic or dextran. Microcarriers enable more cells per milliliter of
culture by expanding the surface area for cell proliferation. More cells in culture increases
overall vaccine titer (yield). With an increase in the use of stirred-tank or single-use bioreactors,
microcarrier innovations have been necessary to allow adherent cells to be cultured in these
conditions. In addition, the use of microcarriers allow manufacturers to increase the number of
cells that can be cultured in one tank enabling more efficient large-scale production and
permitting the use of greater than 1,000 liter bioreactors. SUBs are, in theory, relatively simple
to install and universally applicable by plug and play connections. They are replaced within
shortest time after the process, saving cleaning and sterilization steps while reducing cross-
contamination risks.
Hollow fiber bioreactors have also been used to manufacture viruses. Hollow fiber bioreactors
employ perfusion culture with semipermeable hollow fibers in a cartridge that contains inlet
and outlet ports. The media flows through these fibers providing nutrients to cells. Spent media
can then be filtered and replaced with fresh media or oxygenated and returned.